Analogues of peptide SMAP-29 with comparable antimicrobial potency and reduced cytotoxicity

International Journal of Antimicrobial Agents

Volumn 37, Issue 5, 2011, Pages 432-437

  Dawson, Raymond M ^a   Liu, Chun Qiang ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

Cytotoxicity; Haemolysis; Peptide; SMAP 29; Therapeutic index

Indexed keywords

AMINO ACID DERIVATIVE; PEPTIDE SMAP 29; POLYPEPTIDE ANTIBIOTIC AGENT; SHEEP MYELOID ANTIMICROBIAL PEPTIDE 29; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS ANTHRACIS; BACILLUS SUBTILIS; BURKHOLDERIA; BURKHOLDERIA THAILANDENSIS; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG POTENCY; EMBRYO; ERYTHROCYTE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOLYSIS; HUMAN; HUMAN CELL; LYMPHOCYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACILLUS; BLOOD PROTEINS; BURKHOLDERIA; EPITHELIAL CELLS; ERYTHROCYTES; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTIDES;

EID: 79953907226     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.01.007     Document Type: Article

References (21)

1. Dawson RM, McAllister J, Liu CQ. Characterisation and evaluation of synthetic antimicrobial peptides against Bacillus globigii, Bacillus anthracis and Burkholderia thailandensis. Int J Antimicrob Agents 2010;36:359-63.
2. Dawson RM, Liu CQ. Cathelicidin peptide SMAP-29: comprehensive review of its properties and potential as a novel class of antibiotics. Drug Dev Res 2009;70:481-98.
3. Mock M, Fouet A. Anthrax. Annu Rev Microbiol 2001;55:647-71.
4. Lisanby MW, Swiecki MK, Dizon BLP, Pflughoeft KJ, Koehler TM, Kearney JF. Cathelicidin administration protects mice from Bacillus anthracis spore challenge. J Immunol 2008;181:4989-5000.
5. Whiteaker JR, Warscheid B, Pribil P, Hathout Y, Fenselau C. Complete sequences of small acid-soluble proteins from Bacillus globigii. J Mass Spectrom 2004;39:1113-21. (Pubitemid 39409896)
6. Yu Y, Kim HS, Hui HC, Chi HL, Siew HS, Lin D, et al. Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis. BMC Microbiol 2006;6:46.
7. Zelezetsky I, Pag U, Antcheva N, Sahl H-G, Tossi A. Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin. Arch Biochem Biophys 2005;434:358-64. (Pubitemid 40082045)
8. Kanthawong S, Bolscher JGM, Veerman ECI, van Marle J, Nazmi K, Wongratanacheewin S, et al. Antimicrobial activities of LL-37 and its truncated variants against Burkholderia thailandensis. Int J Antimicrob Agents 2010;36:447-52.
9. Holst CM, Oredsson SM. Comparison of three cytotoxicity tests in the evaluation of the cytotoxicity of a spermine analogue on human breast cancer cell lines. Toxicol In Vitro 2005;19:379-87. (Pubitemid 40248755)
10. Shin SY, Park EJ, Yang ST, Jung HJ, Eom SH, Song WK, et al. Structure-activity analysis of SMAP-29, a sheep leukocytes-derived antimicrobial peptide. Biochem Biophys Res Commun 2001;285:1046-51. (Pubitemid 32918043)
11. Giangaspero A, Sandri L, Tossi A. Amphipathic α helical antimicrobial peptides. Eur J Biochem 2001;268:5589-600.
12. Zelezetsky I, Tossi A. α-Helical antimicrobial peptides-using a sequence template to guide structure-activity relationship studies. Biochim Biophys Acta 2006;1758:1436-49. (Pubitemid 44436080)
13. Tossi A, Sandri L, Giangaspero A. Amphipathic, α-helical antimicrobial peptides. Biopolymers 2000;55:4-30.
14. Tack BF, Sawai MV, Kearney WR, Robertson AD, Sherman MA, Wang W, et al. SMAP-29 has two LPS-binding sites and a central hinge. Eur J Biochem 2002;269:1181-9. (Pubitemid 34175377)
15. Zhu WL, Lan H, Park I-S, Kim JI, Jin HZ, Hahm K-S, et al. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1. Biochem Biophys Res Commun 2006;349:769-74. (Pubitemid 44344580)
16. Yasin B, Pang M, Lehrer RI, Wagar EA. Activity of novispirin G-10, a novel antimicrobial peptide against Chlamydia trachomatis and vaginosis-associated bacteria. Exp Mol Pathol 2003;74:190-5. (Pubitemid 36438669)
17. Strandberg E, Tiltak D, Ieronimo M, Kanithasen N, Wadhwani P, Ulrich AS. Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic α-helical peptides. Pure Appl Chem 2007;79:717-28.
18. Thibault FM, Hernandez E, Vidal DR, Girardet M, Cavallo JD. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. J Antimicrob Chemother 2004;54:1134-8. (Pubitemid 40136755)
19. Zhu WL, Hahm K-S, Shin SY. Cathelicidin-derived Trp/Pro-rich antimicrobial peptides with lysine peptoid residue (Nlys): therapeutic index and plausible mode of action. J Pept Sci 2007;13:529-35. (Pubitemid 47322352)
20. Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, Gilliland SE, et al. Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. J Biol Chem 2006;281:2858-67. (Pubitemid 43845751)
21. Brogden KA, Kalfa VC, Ackermann MR, Palmquist DE, McCray Jr PB, Tack BF. The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob Agents Chemother 2001;45:331-4. (Pubitemid 32039140)